A61K 38/4853
Kallikrein
Official title: {Kallikrein (3.4.21.34 or 3.4.21.35)}
A61K38/4853 (Kallikrein) appears on 40 US grants and 76 published applications in this corpus.
Search patents in A61K- Granted patents
- 40
- Published applications
- 76
- Assignees
- 31
- Inventors
- 83
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 3 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 0 | 4 |
| 2011 | 0 | 3 |
| 2012 | 2 | 6 |
| 2013 | 5 | 8 |
| 2014 | 2 | 7 |
| 2015 | 3 | 2 |
| 2016 | 2 | 3 |
| 2017 | 4 | 6 |
| 2018 | 1 | 0 |
| 2019 | 2 | 2 |
| 2020 | 2 | 2 |
| 2021 | 2 | 5 |
| 2022 | 1 | 1 |
| 2023 | 4 | 2 |
| 2024 | 1 | 6 |
| 2025 | 2 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Dosage forms of tissue kallikrein 117 Jun 2025US 12,329,805 B2DiaMedica Inc.
- Tissue modifier and uses therefor22 Apr 2025US 12,280,095 B2Fibrosoft Pte Ltd
- Dosage forms of tissue kallikrein 12 Jan 2024US 11,857,608 B2DiaMedica Inc.
- Antidotes for factor Xa inhibitors and methods of using the same12 Dec 2023US 11,839,646 B2Alexion Pharmaceuticals, Inc.
- Use of serine protease inhibitors in the treatment of skin diseases24 Oct 2023US 11,793,864 B2Dermadis SA
- Compositions and methods for genome editing4 Jun 2026US 2026/0151507 A1Demeetra Agbio, Inc.
- Dosage forms of tissue kallikrein 16 Nov 2025US 2025/0339500 A1DiaMedica Inc.
- Intravenous compositions of tissue kallikrein-1 and related methods16 Oct 2025US 2025/0319167 A1
- Tissue Modifier And Uses Therefor4 Sep 2025US 2025/0276048 A1Fibrosoft Pte Ltd
- Tissue kallikrein-1 for treating pregnancy disorders31 Jul 2025US 2025/0242001 A1
Most cited
By later US patents
- Long-acting composition230US 4,609,546 AJapan Chemical Research Co., Ltd. · 1986
- Pasteurized therapeutically active protein compositions78US 4,440,679 ACutter Laboratories, Inc. · 1984
- Antidotes for factor Xa inhibitors and methods of using the same27US 8,153,590 B2Portola Pharmaceuticals, Inc. · 2012
- Antidotes for factor Xa inhibitors and methods of using the same26US 8,268,783 B2Portola Pharmaceuticals, Inc. · 2012
- Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents23US 8,455,439 B2Portola Pharmaceuticals, Inc. · 2013